Acetic Acid

Acetic Acid

SCHEMBL5082363

CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].CC(=O)[O-].[Zn+2].[Zn+2]

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.89
CA4 P22748 3/20 0.58
LMNA P02545 2/20 0.50
TSHR P16473 2/20 0.46
THPO P40225 1/20 0.46
FFAR3 O14843 1/20 0.46
LCK P06239 1/20 0.46
FYN P06241 1/20 0.46
ALOX15 P16050 1/20 0.42
BLM P54132 1/20 0.42
PMP22 Q01453 1/20 0.42
FAHD1 Q6P587 1/20 0.42
ALDH1A1 P00352 4/20 0.36
TDP1 Q9NUW8 1/20 0.36
KDM4E B2RXH2 1/20 0.36
CA2 P00918 1/20 0.36
PTGS1 P23219 1/20 0.36
MMP12 P39900 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL51 1.00
Acetic Acid SCHEMBL10578328 1.00 CA1 (0.89) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL14660924 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL9718803 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL8761316 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL7869519 0.95
Acetic Acid SCHEMBL11586801 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL10179054 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL8853012 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO
Acetic Acid SCHEMBL20720790 0.95 CA1 (0.80) CA1CA4LMNATSHRTHPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102651472-B Composite cathode material of lithium ion battery and preparation method thereof SHENZHEN BTR NEW ENERGY MATERIALS CO LTD 2015-06-10 CN claimed
CN-102651472-A Composite cathode material of lithium ion battery and preparation method thereof SHENZHEN BTR NEW ENERGY MATERIALS CO LTD 2012-08-29 CN claimed
US-5374744-A Sex pheronome of Japanese beetle, cupreous chafers; oxidation, reduction, cleavage, cyclization, alkynylation, hydrolysis JAPAN TOBACCO INC. (JP) 1994-12-20 US claimed
EP-0259968-A2 Acrylate hot melt adhesive containing zinc carboxylate MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1988-03-16 EP claimed
JP-3027389-A None JP disclosed
EP-4712948-A2 GENE EDITING SYSTEMS AND COMPOSITIONS FOR TREATMENT OF HEMOGLOBINOPATHIES AND METHODS OF USING THE SAME Renagade Therapeutics Management Inc. (US) 2026-03-25 EP disclosed
WO-2025049959-A9 GENE EDITING SYSTEMS, COMPOSITIONS, AND METHODS FOR TREATMENT OF VEXAS SYNDROME RENAGADE THERAPEUTICS MANAGEMENT INC. (US) 2025-06-12 WO disclosed
EP-4565258-A2 COMPOSITIONS FOR THE TREATMENT OF DISEASE Sightstream Biotherapeutics, Inc. (US) 2025-06-11 EP disclosed
US-12319929-B2 Compositions and methods for the treatment of Parkinson's disease VOYAGER THERAPEUTICS, INC. (US) 2025-06-03 US disclosed
US-12305189-B2 Compositions and methods for delivery of AAV VOYAGER THERAPEUTICS, INC. (US) 2025-05-20 US disclosed
WO-2025049959-A2 GENE EDITING SYSTEMS, COMPOSITIONS, AND METHODS FOR TREATMENT OF VEXAS SYNDROME RENAGADE THERAPEUTICS MANAGEMENT INC. (US) 2025-03-06 WO disclosed
EP-4501318-A2 NUCLEIC ACID VACCINES ModernaTX, Inc. (US) 2025-02-05 EP disclosed
EP-0274066-B1 BENZOTHIAZOLONES, AND THEIR PRODUCTION AND USE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1993-03-17 EP disclosed
US-5079368-A Chemical intermediate for herbicides SUMITOMO CHEMICAL COMPANY LIMITED (JP) 1992-01-07 US disclosed
JP-H0327389-A ANTI-BACTERIAL AGENT MEDIOLANUM FARMACEUT SRL 1991-02-05 JP disclosed
US-4946961-A HERBICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1990-08-07 US disclosed
US-4888045-A HERBICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-12-19 US disclosed
US-4773933-A TEMPORARY SEALS IN TEETH G-C DENTAL INDUSTRIAL CORP. (JP) 1988-09-27 US disclosed
EP-0274066-A2 Benzothiazolones, and their production and use SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1988-07-13 EP disclosed
US-4522806-A Oral compositions for hexetidine and zinc salts for the synergistic inhibition of dental plaque LEVER BROTHERS COMPANY (US) 1985-06-11 US disclosed